4bof: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
No edit summary
OCA (talk | contribs)
No edit summary
Line 7: Line 7:
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4bof FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4bof OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4bof RCSB], [http://www.ebi.ac.uk/pdbsum/4bof PDBsum]</span></td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4bof FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4bof OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4bof RCSB], [http://www.ebi.ac.uk/pdbsum/4bof PDBsum]</span></td></tr>
</table>
</table>
== Function ==
[[http://www.uniprot.org/uniprot/ARCA_STRPY ARCA_STRPY]] Antitumor protein. Has a powerful and dose-dependent inhibitory effect on antigen, superantigen, or mitogen-stimulated human peripheral blood mononuclear cell (PBMC) proliferation. It may inhibit cell proliferation by arresting cell cycle and inducing apoptosis (By similarity).[HAMAP-Rule:MF_00242]
<div style="background-color:#fffaf0;">
<div style="background-color:#fffaf0;">
== Publication Abstract from PubMed ==
== Publication Abstract from PubMed ==